Testing the Effectiveness of a Work Rehabilitation Intervention for Women with Breast Cancer
CanWork
Examining the Effectiveness, and Cost-effectiveness, of CanWork, a Self-management Intervention to Support Women with Breast Cancer to Return to Work
1 other identifier
interventional
248
1 country
2
Brief Summary
Women with breast cancer make up a significant proportion of cancer survivors, with more than 43,750 women living with breast cancer in Ireland. However, many women report physical and psychological health difficulties that interfere with their ability to return to work. In Ireland, and internationally, these difficulties are being increasingly recognised, with recent research identifying gaps in rehabilitation services to prepare women with breast cancer to return to work. Collaborating with women with breast cancer, and those who provide health and supportive services to individuals living with cancer in Ireland, an online self-management intervention, CanWork, was developed. CanWork aims to support women with breast cancer to manage the process of returning to work and learn strategies to manage post-treatment health-related difficulties. CanWork also provides information on workplace entitlements. This intervention was trialled with women with breast cancer in 2021, who reported that the programme gave them confidence to return to work and that the content was relevant. This study will include a larger group of women with breast cancer to determine if CanWork is effective in supporting return to work. To do this, 248 women with breast cancer will be included in the study, half of whom will receive CanWork and the results will be compared with women who do not receive the intervention. Having a programme that is financially viable is important and therefore the costs involved in running and attending the intervention will also be calculated. Should this study demonstrate that CanWork is effective in supporting women with breast cancer to return to work, the study team will collaborate with cancer services in Ireland to make the programme available nationally.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Nov 2024
Typical duration for not_applicable breast-cancer
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2024
CompletedFirst Submitted
Initial submission to the registry
December 4, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2028
December 17, 2024
December 1, 2024
2.9 years
December 4, 2024
December 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Return to work: Yes/No.
The primary outcomes measure used in the feasibility study of CanWork was a self-report binary question of "Return to Work (RTW): Yes/No. This measure was identified in a systematic review as the most commonly used work-related measure in the included studies. RTW refers to any work resumption irrespective of number of hours a participant worked before their diagnosis. Participants will be asked immediately post-intervention, at three, six and 12-month follow-up periods if they have returned to work, on what date they returned and number of hours/week currently working
From enrolment to 12-months following enrolment
Return to Work Self-efficacy (RTW-SE) questionnaire
The RTW-SE measure is a short ten-item questionnaire that asks participants to rate their level of confidence on a Likert scale of 1-10 to manage physical, psychological and emotional demands of work. Recent research has found that both the baseline RTW-SE score and subsequent increases in the RTW-SE score during return-to-work interventions are robust predictors of return to work.
From enrolment to 12-months following enrolment
Secondary Outcomes (4)
Readiness to return to work
From enrolment to 12-months following enrolment
Return to Work log book
From enrolment to 12-months following enrolment
EORTC QLQ-30
From enrolment to 12-months following enrolment
PROMIS Self-Efficacy for Managing Symptoms
From enrolment to 12-months following enrolment
Other Outcomes (1)
ICECAP-A (ICEpop CAPability measure for Adults)
From study enrolment to 12-months following enrolment
Study Arms (2)
Intervention arm
EXPERIMENTALThe intervention arm will receive an online occupational therapy intervention, CanWork, to increase knowledge and skills of women with breast cancer to manage cancer-related symptoms that interfere with return to work. It consists of five, 90-minute group-based modules and an individual meeting between the occupational therapist facilitator and each participant. Each of the group-based modules consists of two components. The first component focuses on education and peer-led discussion of cancer-related symptom management and supports available to manage difficulties in work. Topics covered each week include managing fatigue in work, understanding cancer-related cognitive impairments, strategies for managing physical and mental health in work and effective communication with employers and colleagues.
Comparator group
NO INTERVENTIONThis group will act as a comparison group to the intervention arm. Study participants (women with breast cancer) in this group will not receive the CanWork intervention but will receive standard supportive care provided in their local community cancer support centre
Interventions
CanWork is an online, occupational therapy intervention to develop knowledge and skills to manage cancer-related symptoms that interfere with return to work. It consists of five, 90-minute group-based modules and an individual meeting between the occupational therapist facilitator and each participant. Each of the five-week group-based modules consists of two components: (i) education and peer-led discussion of cancer-related symptom management and supports available to manage difficulties in work and (ii) goal setting to facilitate application of knowledge and skills to work-related activities. Weekly topics include managing fatigue in work, understanding cancer-related cognitive impairments, strategies for managing physical and mental health in work and effective communication with employers and colleagues. The individual meeting between each participant and the occupational therapist is focused on designing a tailored return to work plan for each participant.
Eligibility Criteria
You may qualify if:
- Women with confirmed diagnosis of breast cancer
- Women with breast cancer who were in paid employment prior to their cancer diagnosis
- Women with breast cancer who have completed adjuvant oncology treatment (excluding hormone therapy, targeted and biological therapies) within the last 12 months
- Women with breast cancer who have capacity to participate in a six-week online occupational therapy intervention
You may not qualify if:
- Women with metastatic breast cancer
- Women with breast cancer who were not in paid employment prior to their cancer diagnosis
- Women with breast cancer who have decided not to return to work following completion of cancer treatment
- Women with breast cancer who have co-morbidity that would interfere with capacity to participate in a six-week online occupational therapy intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Dublin, Trinity Collegelead
- National Cancer Control Programme, Irelandcollaborator
- Royal College of Surgeons, Irelandcollaborator
- University of Galwaycollaborator
Study Sites (2)
Cancer Care West
Galway, Ireland
Solas Cancer Support Centre
Waterford, Ireland
Related Publications (1)
Pallin ND, Algeo N, O'Connor ME, Connolly H, Lowry M, Bennett K, Gillespie P, Hobbins A, Gallagher P, Mullen L, Lyons KD, McHugh SM, Connolly D. A cluster randomised controlled trial to test the effectiveness and cost-effectiveness of a self-management intervention to support women with breast cancer to return to work: A study protocol. Contemp Clin Trials. 2025 Dec 15;161:108185. doi: 10.1016/j.cct.2025.108185. Online ahead of print.
PMID: 41407101DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deirdre Connolly, PhD
University of Dublin, Trinity College
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor in Occupational Therapy
Study Record Dates
First Submitted
December 4, 2024
First Posted
December 9, 2024
Study Start
November 13, 2024
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
March 31, 2028
Last Updated
December 17, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Ethical approval has not been obtained to share IPD